Zobrazeno 1 - 6
of 6
pro vyhledávání: '"F M, Mazzella"'
Autor:
F M Mazzella, M A Shrit, Areta Kowal-Vern, James Cotelingam, Harold R. Schumacher, James T. Rector
Publikováno v:
Modern Pathology. 13:407-413
Acute erythroleukemia is a relatively rare disorder of a multilineal nature. Patients with this type of leukemia traditionally have been treated with a standard myeloid protocol, with a wide variation in prognosis between M6a, which has a similar pro
Publikováno v:
American journal of hematology. 65(1)
Acute erythroleukemia (FAB M6) is a rare heterogeneous disease with an increase in red cell precursors and myeloblasts. Three subsets have been described: M6A (myeloblast-rich erythroleukemia); M6B (proerythroblast-rich erythroleukemia); and M6C (mye
Publikováno v:
Clinics in laboratory medicine. 20(1)
Acute erythroleukemia is an aggressive leukemia derived from a multipotential stem cell. Three subtypes have been described: (1) M6a with greater than or equal to 30% blasts of the nonerythrocytic component, (2) M6b with greater than or equal to 30%
Publikováno v:
Connecticut medicine. 60(9)
This is a case of a long-term Connecticut resident who presented with both human granulocytic ehrlichiosis and Lyme disease. The etiologic agents and the probability of coinfection are discussed.
Autor:
F. M. Mazzella, Andre M. Kallab, Celalettin Ustun, P. A. Bilodeau, Anand Jillella, S. D. Mendpara
Publikováno v:
Bone Marrow Transplantation. 30:259-260
Cryptococcal meningitis following autologous stem cell transplantation in a patient with multiple myeloma
Autor:
F M Mazzella, H R Schumacher
Publikováno v:
Journal of Clinical Pathology. 55:800-800
Our group has been actively researching the acute erythroleukaemias since the late 1980s, during which time, we have developed and extensively published our classification1–5: We have also published abstracts and presented this classification at me